Christine Ann Miller

Christine Ann Miller

Amministratore Delegato presso MELINTA THERAPEUTICS, INC.
50 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Christine Ann Miller is President, Chief Executive Officer & Director at Melinta Therapeutics, Inc. since 2020.
Ms. Miller is Chairman of the Antimicrobials Working Group since 2023.
Former roles include President & Chief Executive Officer at Cempra Pharmaceuticals, Inc., Independent Director at IVERIC bio, Inc. from 2022 to 2023, and Global Head-Portfolio & Enterprise at Sandoz, Inc. from 2018 to 2020.
Education includes graduate and Masters of Business Administration degrees from Stevens Institute of Technology and an undergraduate degree from Rensselaer Polytechnic Institute.

Posizioni attive di Christine Ann Miller

SocietàPosizioneInizio
MELINTA THERAPEUTICS, INC. Amministratore Delegato 03/08/2020
Presidente 17/01/2023

Precedenti posizioni note di Christine Ann Miller

SocietàPosizioneFine
IVERIC BIO, INC. Direttore/Membro del Consiglio 11/07/2023
Corporate Officer/Principal 01/01/2020
Amministratore Delegato -
Vedi nel dettaglio l'esperienza di Christine Ann Miller

Formazione di Christine Ann Miller

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

23

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Commercial Services

  1. Mercati
  2. Insiders
  3. Christine Ann Miller